For the Inventor, By the Inventor

Enter assignee name

Tiverton, RI, United States of America

Veroscience LLC

USPTO Granted Patents = 42

% Expired Patents = 4.8

EPO Patents = 10

Trademarks = 7

Forward Citations = 638

Loading Chart...

Loading Chart...

5 inventors (with patents filed for the assignee):

Anthony H Cincotta (42 out of 91 patents)

Craig Michael Bowe (11 out of 15 patents)

Laura Jean Weston (11 out of 12 patents)

4. Paul Clark Stearns (10 out of 10 patents)

5. Paul Clark Steams (1 out of 1 patent)

6. Alex Nivorozhkin (32 patents)

7. Nelson Landrau (21 patents)

8. Anthony Cinotta (0 patent)

9. Anthony Cinotta (0 patent)

Core Competencies:

Bromocriptine Formulations

Dopamine Agonists

Metabolic Syndrome

Type 2 Diabetes

Obesity

Prediabetes

Tumor Regression

Insulin Secretagogues

Therapeutic Process

Parenteral Formulations

Metabolic Conditions

Dopamine Receptor Agonists

42 patents: Sort by Forward Citations

1. 12668590 - Composition and method for treating metabolic disorders (2026-06-30),

2. 12616693 - Bromocriptine formulations (2026-05-05),

3. 12492198 - Composition and method for treating metabolic disorders (2025-12-09),

4. 12357693 - Method for inducing tumor regression (2025-07-15),

5. 12318451 - Method for inducing tumor regression (2025-06-03),

6. 12274698 - Bromocriptine formulations (2025-04-14),

7. 11883399 - Bromocriptine formulations (2024-01-30),

8. 11878974 - Composition and method for treating metabolic disorders (2024-01-23),

9. 11666567 - Bromocriptine formulations (2023-06-06),

10. 11607455 - Method for inducing tumor regression (2023-03-21),

11. 11560375 - Composition and method for treating metabolic disorders (2023-01-24),

12. 11510921 - Bromocriptine formulations (2022-11-29),

13. 11241429 - Method of treating metabolic disorders and depression with dopamine receptor agonists (2022-02-08),

14. 11045464 - Parenteral formulations of dopamine agonists (2021-06-29),

15. 11000522 - Bromocriptine formulations (2021-05-11),

Veroscience LLC, based in Tiverton, RI, specializes in innovative therapeutic solutions targeting metabolic disorders. The company focuses on the development of advanced formulations of bromocriptine and other dopamine receptor agonists, aimed at addressing conditions such as metabolic syndrome, type 2 diabetes, and obesity. With a commitment to improving patient outcomes, Veroscience is dedicated to research and development in parenteral formulations that enhance the efficacy of treatments for tumor regression and related metabolic challenges.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

42 Patents

#1 in Tiverton, RI

#49 in Rhode Island

#8,253 in US

#16,338 in the World

Tiverton, RI, United States of America

Veroscience LLC

Forward Citations = 638

5 inventors:

Anthony H Cincotta (42 out of 91 patents)

Craig Michael Bowe (11 out of 15 patents)

Laura Jean Weston (11 out of 12 patents)

4. Paul Clark Stearns (10 out of 10 patents)

5. Paul Clark Steams (1 out of 1 patent)

Please report any incorrect information to [email protected]

Loading…